Expression of glomerular epithelial protein 1 (GLEPP1), a receptor tyrosine phosphatase present on the apical cell surface of the glomerular podocyte, and podocyte morphology were investigated in renal specimens from 51 patients with biopsy-diagnosed immunoglobulin A nephropathy (IgAN) and 11 controls. Clinical parameters, such as daily proteinuria were obtained from the patients' records and pathological manifestations of IgAN in the specimens were graded. GLEPP1 was strongly expressed and diffusely distributed in the glomeruli of control specimens. GLEPP1 expression was reduced in IgAN, especially in patients with nephrotic proteinuria and severe pathological manifestations. Podocyte injury was evident in IgAN and was associated with lower GLEPP1 expression and higher pathological grade. GLEPP1 expression was also significantly associated with clinical parameters. The results of this study suggest that GLEPP1 expression may be a useful marker of podocyte injury in IgAN, and may be predictive of clinical and pathological severity.
DaskalakisNWinnMP: Focal and segmental glomerulosclerosis: Varying biologic mechanisms underlie a final histopathologic end point. Semin Nephrol2006; 26: 89–94.
ChenCAHwangJCGuhJY: Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats. J Lab Clin Med2006; 147: 74–82.
4.
KaplanJMKimSHNorthKN: Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet2000; 24: 251–256.
5.
White KE, Bilous RW, for the Diabiopsies Study Group: Structural alterations to the podocyte are related to proteinuria in type 2 diabetic patients. Nephrol Dial Transplant2004; 19: 1437–1440.
6.
PatrakkaJLahdenkariATKoskimiesO: The number of podocyte slit diaphragms is decreased in minimal change nephrotic syndrome. Pediatr Res2002; 52: 349–355.
7.
KimYHGoyalMWharramB: GLEPP1 receptor tyrosine phosphatase (Ptpro) in rat PAN nephrosis. A marker of acute podocyte injury. Nephron2002; 90: 471–476.
8.
SharifKGoyalMKershawD: Podocyte phenotypes as defined by expression and distribution of GLEPP1 in the developing glomerulus and in nephrotic glomeruli from MCD, CNF, and FSGS. A dedifferentiation hypothesis for the nephrotic syndrome. Exp Nephrol1998; 6: 234–244.
9.
LeeSM: Prognostic indicators of progressive renal disease in IgA nephropathy: Emergence of a new histologic grading system. Am J Kidney Dis1997; 29: 953–958.
10.
EikmansMBaeldeHJde HeerE: Effect of age and biopsy site on extracellular matrix mRNA and protein levels in human kidney biopsies. Kidney Int2001; 60: 974–981.
11.
SrivastavaTGarolaREWhitingJM: Synaptopodin expression in idiopathic nephrotic syndrome of childhood. Kidney Int2001; 59: 118–125.
12.
DrumondMCKristalBMyersBD: Structural basis for reduced glomerular filtration capacity in nephrotic humans. J Clin Invest1994; 94: 1187–1195.
13.
KrizWHackenthalENobilingR: A role for podocytes to counteract capillary wall distension. Kidney Int1994; 45: 369–376.
14.
GagliardiniEBenigniATomasoniS: Targeted downregulation of extracellular nephrin in human IgA nephropathy. Am J Nephrol2003; 23: 277–286.
15.
QiuLQSinniahRHsuS I-Hong: Downregulation of Bcl-2 by podocytes is associated with progressive glomerular injury and clinical indices of poor renal prognosis in human IgA nephropathy. J Am Soc Nephrol2004; 15: 79–90.
16.
Wagrowska-DanilewiczMStasikowskaODanilewiczM: Immunoexpression of podocyte-associated proteins in acquired human glomerulopathies with nephrotic syndrome. Pol J Pathol2006; 57: 17–21.
17.
AsanumaKMundelP: The role of podocytes in glomerular pathobiology. Clin Exp Nephrol2003; 7: 255–259.
18.
LemleyKVLafayetteRASafaiM: Podocytopenia and disease severity in IgA nephropathy. Kidney Int2002; 61: 1475–1485.
19.
HishikiTShiratoITakahashiY: Podocyte injury predicts prognosis in patients with IgA nephropathy using a small amount of renal biopsy tissue. Kidney Blood Press Res2001; 24: 99–104.
20.
WigginsRCWigginsJEGoyalM: Molecular cloning of cDNAs encoding human GLEPP1, a membrane protein tyrosine phosphatase: Characterization of the GLEPP1 protein distribution in human kidney and assignment of the GLEPP1 gene to human chromosome 12p12- p13. Genomics1995; 27: 174–181.
21.
YangDHGoyalMSharifK: Glomerular epithelial protein 1 and podocalyxin-like protein 1 in inflammatory glomerular disease (crescentic nephritis) in rabbit and man. Lab Invest1996; 74: 571–584.
22.
ThomasPEWharramBLGoyalM: GLEPP1, a renal glomerular epithelial cell (podocyte) membrane protein-tyrosine phosphatase. Identification, molecular cloning, and characterization in rabbit. J Biol Chem1994; 269: 19953–19962.
23.
WharramBLGoyalMGillespiePJ: Altered podocyte structure in GLEPP1 (Ptpro)- deficient mice associated with hypertension and low glomerular filtration rate. J Clin Invest2000; 106: 1281–1290.
24.
KoopKEikmansMBaeldeHJ: Expression of podocyte-associated molecules in acquired human kidney diseases. J Am Soc Nephrol2003; 14: 2063–2071.
25.
WharramBLGoyalMWigginsJE: Podocyte depletion causes glomerulosclerosis: Diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol2005; 16: 2941–2952.
26.
HirakawaMTsuruyaKYotsuedaH: Expression of synaptopodin and GLEPP1 as markers of steroid responsiveness in primary focal segmental glomerulosclerosis. Life Sci2006; 79: 757–763.
27.
NakamuraTUshiyamaCSuzukiS: Effects of angiotensin-converting enzyme inhibitor, angiotensin II receptor antagonist and calcium antagonist on urinary podocytes in patients with IgA nephropathy. Am J Nephrol2000; 20: 373–379.
28.
BartosikLPLajoieGSugarL: Predicting progression in IgA nephropathy. Am J Kidney Dis2001; 38: 728–735.
